Floatz logo

Novaferon

Neuroendocrine Tumors

The Affiliated Hospital of the Chinese Academy of Military Medical Sciencesprotein_peptidePhase 2Dormant
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
73/ 100

Competitive context

56 Active assets in the Neuroendocrine Tumors cohort.

Asset / SponsorPhaseRating
Irinotecan
First Affiliated Hospital Xi'an Jiaotong University
Phase 4BB
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Institute (NCI)
Phase 4BB
Eloxatin
ITM Solucin GmbH
Phase 3BB
Surufatinib
Shanghai Changzheng Hospital
Phase 3BB
Oxodotreotide
Fundación de investigación HM
Phase 3BB

View all 50 →

Same molecule, other indications

Novaferon is also rated in:

colorectal cancerDormant
CCC
Indicative ·
51 / 100
View asset →
hepatocellular carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
fibrolamellar hepatocellular carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →